CD1D and metabolic dysfunction-associated steatohepatitis: NKT cells actively promote fibrogenesis in NASH; CD1d-deficient mice that lack NKT cells are protected from NASH-related fibrosis, whereas treatment of primary HSCs with α-galactosyl-ceramide-activated NKT cells stimulates activation of HSCs to become myofibroblast-like [112].